These amazing researchers are the backbone of helping us find a cure to Pancreatic Cancer. Sky awards seed grants for pancreatic cancer medical research, which provide initial funding to researchers for exploratory studies. These grants support innovative ideas, gather preliminary data, and encourage scientists to pursue their research further. Such funding plays a crucial role in kickstarting early-stage investigations and supports new approaches that will potentially lead to more significant research opportunities that may one day be the breakthrough to cure pancreatic cancer.
University Of Pittsburgh Medical Center Dr. Singhi is a surgical pathologist with sub-specialty training in gastrointestinal, liver, and pancreatobiliary pathology.
Adrianne Wallace-Povirk, PhD Henry Ford Health System, Pancreatic Cancer Center Postdoctoral Fellow, Dr. Howard Crawford Laboratory and co-mentored by Dr.
Chris Halbrook, PhD Assistant Professor Department of Molecular Biology and Biochemistry Chao Family Comprehensive Cancer Center Christopher Halbrook, PhD, is
Harrison L Hiraki, PhD University of Michigan, Department of Surgery Rogel and Blondy Center for Pancreatic Cancer Title of Research: Organotypic microfluidic system
Howard C. Crawford, PhD Scientific Director, Henry Ford Pancreatic Cancer Center | Chief Scientific Officer, Sky Foundation Scientific Advisory Committee
Jiao Shen Dana-Farber Cancer Institute Project Title: "Identification of KRAS-specific TCRs from human peripheral blood" We developed an efficient platform
Jurgis Alvikas, MD Complex General Surgical Oncology Fellow University of Pittsburgh Medical Center Project Description: "Platelet RNA signatures for early
Lindeberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Kirsten L. Bryant, PhD Assistant Professor, Department of Pharmacology
Lisa Miller-Phillips, MD Postdoctoral Scholar, Medicine School of Medicine University of California San Francisco Project Title: Histological and transcriptional
Sanford-Burnham-Prebys Medical Discovery Institute, University Of California, San Diego My lab recently found that a single gene reprograms pancreatic cancer cells back
Peter Wang, PhD Massachusetts General Hospital Project Description: "Deciphering how cancer induced nerve injury affects immune responses in PDAC" This